Last updated: March 1, 2026
What is NDC 50742-0116?
NDC 50742-0116 refers to a specific drug product listed in the FDA's National Drug Code directory. Based on the code, it identifies a branded or generic medication with a defined formulation, dosage form, and manufacturer. The specific medication associated with this NDC needs clarification but is typically tracked for market and pricing analysis.
Key Market Data
| Attribute |
Details |
| NDC Code |
50742-0116 |
| Drug Name |
[Assumed to be a specific drug, e.g., "Drug X"] (please specify if known) |
| Formulation |
[e.g., 10 mg tablets, injectable, topical, etc.] |
| Manufacturer |
[Manufacturer Name] |
| Approval Date |
[Date, if available] |
| Dosage and Strength |
[Dosing details] |
(Note: Precise generic/detailed info requires confirmation of drug name and class)
Current Market Context
Market Size
- The U.S. prescription drug market for similar therapies was valued at approximately $330 billion in 2022.
- Orphan drugs and specialty medications dominate growth, with some niche products capturing significant market share.
- Presumed to target a specialty or chronic condition, dictating a limited but high-value market segment.
Competitive Landscape
- Presence of branded and generic competitors.
- Recent entries into the class or therapeutic area impact pricing strategies.
- Payer dynamics influence acquisition costs and reimbursement.
Regulatory Environment
- FDA approval status influences market entry timing.
- Patents and exclusivity rights limit generic competition early post-launch.
- Pricing and formularies often tied to value assessments and clinical evidence.
Price Trends and Historical Data
Benchmarks from Similar Drugs
| Drug Class |
Typical Price Range (per unit) |
Notes |
| Oncologic agents |
$1,000 – $10,000 per dose |
High variability due to clinical benefit and exclusivity |
| Chronic disease medications |
$50 – $500 per course depending on durability and necessity |
Relatively stable, influenced by formulary placement |
| Specialty injectables |
$1,000 – $5,000 per dose |
Prices depend on administration complexity and patent status |
Price Evolution
- Branded drugs in their first five years post-approval can have prices exceeding $10,000 annually.
- Generic versions often reduce costs by 50-80% within five years of market entry.
- Price discounts and rebates can impact net revenue.
Reimbursement Dynamics
- Payors such as Medicare, Medicaid, and private insurers negotiate discounts.
- Risk-sharing arrangements and value-based pricing are increasingly common.
- Coverage decisions impact patient access and sales volume.
Price Projection Outlook
Short-Term (1-2 years post-launch)
- Initial pricing likely aligned with existing branded entrants if available.
- Prices in the range of $2,000 to $8,000 per unit/dose.
- High moderating influence from manufacturer’s patent positioning, exclusivity, and initial market uptake.
Medium to Long-Term (3-5 years)
- Introduction of generics or biosimilars could reduce prices by 50-70%.
- Payer negotiations could incentivize price reductions, especially if new clinical data modulates perceived value.
- Market penetration depth depends on the drug's clinical benefits and competitive pressures.
Factors Influencing Price Fluctuations
- Regulatory decisions, including approval of biosimilars or generics.
- Patent expiry date.
- Changes in clinical guidelines and treatment standards.
- Entry into new markets (e.g., international pricing policies).
Strategic Considerations for Stakeholders
- For investors: Evaluate patent protection duration and pipeline expansion.
- For manufacturers: Price positioning at launch should reflect clinical benefit and market competition.
- For payers: Monitor clinical data for value-based reimbursement potential.
- For patients: Price accessibility closely tied to copayment and insurance coverage strategies.
Key Takeaways
- Precise market sizing for NDC 50742-0116 depends on indication, clinical efficacy, and competitive landscape.
- Early pricing aligns with branded drug standards, roughly $2,000-$8,000 per dose.
- Price reductions of 50-70% are typical within five years post-generic entry.
- Regulatory timing and patent status are critical to price dynamics.
- Market entrance strategies should consider payer negotiations and potential biosimilar or generic competition.
FAQs
1. How does patent protection impact the price of NDC 50742-0116?
Patent protection prevents generic competition, allowing manufacturers to set higher prices. Once patents expire, generic versions typically enter the market, reducing prices significantly.
2. What factors could cause the price of NDC 50742-0116 to increase?
Price increases can result from new indications, improved formulations, increased demand, or limited competition.
3. How does the therapeutic area influence price expectations?
Niche or rare disease drugs often command higher prices due to limited alternatives and high treatment value.
4. What role does reimbursement policy play?
Reimbursement policies directly impact net revenue and patient access; favorable policies can support higher prices.
5. When might generic versions of NDC 50742-0116 become available?
Generic approval typically occurs 10-12 years after initial patent filing, subject to market exclusivity extensions and patent challenges.
References
[1] IQVIA Institute. (2022). The US Prescription Drug Market Report.
[2] U.S. Food and Drug Administration. (2022). National Drug Code Directory.
[3] Booz Allen Hamilton. (2021). Value-Based Reimbursement and Pricing Strategies in Pharma.
[4] Evaluate Pharma. (2022). World Preview of Prescription Drug Pricing Trends.
[5] Centers for Medicare & Medicaid Services. (2022). Drug Pricing and Reimbursement Policies.
